Concerta, a popular ADHD medication being prescribed to adolescents across the country is coming under strict scrutiny as a result of recent studies calling into question the safety of the drug.

A recent study in the Drug Safety Journal found a 162-fold increase in suicide rates for the under-14 age group in patients taking ADHD

Such is the case in the broadening discovery of NDMA in a variety of pharmaceutical drugs, that hasn’t near received the attention it deserves.

NDMA is an industrial chemical known as n-nitrosidomethylamin (NDMA).  It’s presence should not be detected in any pharmaceutical drugs as the chemical is classified by the Environmental Protection Agency (EPA) as

This week eight teenagers in Wisconsin were admitted to the hospital for suffering severe lung disease believed to be linked to e-cigarettes.  Shortly after the news story broke, Illinois also announced that they had minors admitted to the emergency room as well and diagnosed with the same lung disease.
CNN.com reported that physicians interviewed reported

The Mesothelioma frontier continues to build against Johnson & Johnson and their talculm-powder based products.

Late last week a New York State Jury awarded a woman diagnosed with mesothelioma, who contended that her disease was related to her years of use of Johnson & Johnson’s talculm baby powder, millions.  The jury found that J&J’s talculm

The US Food and Drug Administration on April 30, 2019 required revised warnings on a host of popular and often used sleep aides warning of a whole host of dangerous risks that have been linked to the drugs.

The drugs, such as Lunesta and Ambien, have been linked to 66 examples of patients who took

The US Food and Drug Administration recently issues their strongest warning, known as the “black box” warning, to Takeda Pharmaceuticals, who manufactures the popular gout medicine, Uloric.

The FDA warning states in part:

The U.S. Food and Drug Administration (FDA) has concluded there is an increased risk of death with Uloric (febuxostat) compared to another

FDA Announces Valsartan Recall

In July 2018, the U.S. Food and Drug Administration (FDA) issued a recall of a number pharmaceutical drugs containing valsartan used to treat hypertension (high blood pressure) and heart failure due to the increased risk of certain cancers associated with NDMA. Not all drugs containing valsartan were named in the recall.